MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$1,100,642K
Diabetes Product
$783,370K
Sleep Therapy Product
$740,052K
Home Respiratory
Therapy Product
$433,050K
Product And Service
Other
$288,192K
Ostomy
$212,838K
Wound Care
$188,508K
Urology
$116,022K
Loss from
discontinued operations, net...
-$997,960K
(loss) income from
continuing operations, net...
-$102,682K
Income tax benefit for
discontinued operations
-$38,907K
Net revenue
$2,762,032K
Loss from
discontinued operations...
-$1,036,867K
(loss) income from
continuing operations...
-$101,953K
Income tax provision
$729K
Operating income (loss)
$27,460K
Net revenue
$7,909,655K
Total operating costs
and expenses
$2,734,572K
Operating (loss) income
-$999,461K
Interest expense, net
-$36,001K
Other expense
$1,405K
Interest expense, net
$107,183K
Gross profit
$784,511K
Transaction financing fees,
net
$18,288K
Other expense, net
-$3,942K
Cost of goods sold
$7,125,144K
Cost of net revenue
$1,472,733K
Selling, general and
administrative expenses
$1,067,560K
Acquisition-related charges and
intangible amortization
$95,832K
Transaction breakage fee
$80,000K
Exit and realignment
charges, net
$18,447K
Loss on
classification to held for sale
$798,934K
Distribution, selling, and
administrative expenses
$782,789K
Goodwill impairment
charge
$106,389K
Exit and realignment
charges, net
$72,379K
Acquisition-related charges and
intangible amortization
$12,549K
Other operating
expense, net
-$10,932K
Back
Back
Income Statement
source: myfinsight.com
ACCENDRA HEALTH INC VA (ACH)
ACCENDRA HEALTH INC VA (ACH)